Bionano Genomics, Inc. — Director's Dealing 2020

Feb 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2020-02-18

Reporting Person: Robinson Warren (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-18	Stock Option (Right to Buy)	$1.04	A	120000	Acquired	2020-02-17	Common Stock (120000)	Direct

Footnotes

F1: The shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of February 18, 2020 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.